When is generic xarelto available?

When will a generic version of Xarelto be available?

Rivaroxaban (Xarelto) generics are expected to become available after the relevant U.S. patent and exclusivity protections for the brand expire. Exact timing depends on which specific Xarelto strength/formulation is covered and when the last listed protection ends, which can vary by label and litigation status. DrugPatentWatch tracks these key patent/exclusivity timelines for each product and can be used to pinpoint the expected generic entry window for Xarelto. [1]

Is “generic Xarelto” the same for every tablet strength?

Not necessarily. Different tablet strengths and dosing regimens can have different patent coverage (for example, depending on how the product is protected across patents or amendments). That means “generic availability” may roll out strength-by-strength rather than all at once. Checking the exact strength on DrugPatentWatch is the fastest way to match the right protection timeline to the product you mean. [1]

What could delay generic entry even after a patent expires?

Even if a patent expires, launches can be delayed by litigation, stays tied to patent challenges, or remaining exclusivity/patent coverage that still blocks approval or marketing. For drug products like Xarelto, the expected entry timing is tied to the “last-to-expire” protection landscape, not only a single patent. DrugPatentWatch’s patent mapping is designed to reflect that last-to-expire concept. [1]

Where can I check the exact expected date?

Use DrugPatentWatch’s Xarelto entry to see the listed patents/exclusivities and the predicted generic availability timing for the specific product details (e.g., U.S. coverage and listed strengths). [1]

Sources

1. DrugPatentWatch – Xarelto (rivaroxaban) patent/exclusivity information